Tetraphase Pharmaceuticals

Tetraphase Pharma’s Antibiotic Wins FDA Approval for Gut Infections
Tetraphase Pharma’s Antibiotic Wins FDA Approval for Gut Infections
Xconomy
Tetraphase Pharmaceuticals
Xerava
FDA
antibiotics
cIAI
complicated intra-abdominal infections
Flag link:
Mid-FDA Review, Tetraphase Stumbles Again on Latest Phase 3 Setback
Mid-FDA Review, Tetraphase Stumbles Again on Latest Phase 3 Setback
Xconomy
FDA
Tetraphase Pharmaceuticals
clinical trials
Eravacycline
antibiotics
Flag link:
New antibiotic therapies: what future?
New antibiotic therapies: what future?
GoinPharma
antibiotics
Merck
Paratek
Tetraphase Pharmaceuticals
Motif Biosciences
The Medicines Company
Flag link:
4 Key FDA Decisions Expected By Year End
4 Key FDA Decisions Expected By Year End
24/7 Wall St
FDA
Achillion
hepatitis C
Biocryst
OPuS-2
BCX4161
Tetraphase Pharmaceuticals
Lucitanib
Clovis Oncology
Flag link:
Biotechs Coming Off One Of The Busiest Weeks In Recent Memory
Biotechs Coming Off One Of The Busiest Weeks In Recent Memory
Yahoo/Benzinga
biotech
Gilead Sciences
Akebia
Vitae
Clovis Oncology
AstraZeneca
Bristol-Myers Squibb
Flexion
Tetraphase Pharmaceuticals
Flag link:
Tetraphase Pharmaceuticals Antibiotic Fails Against J&J Drug In Trial; Stock Plunges 79% After-Hours
Tetraphase Pharmaceuticals Antibiotic Fails Against J&J Drug In Trial; Stock Plunges 79% After-Hours
Bidness, ETC
Tetraphase Pharmaceuticals
JNJ
antibiotics
Eravacycline
superbugs
Flag link:
3 Biotech Stocks to Buy With Huge Catalysts Coming Soon
3 Biotech Stocks to Buy With Huge Catalysts Coming Soon
24/7 Wall St
Biomarin
drisapersen
Cempra
Solithromycin
antibiotics
Tetraphase Pharmaceuticals
Eravacycline
Flag link:
2 Biotech Buyout Candidates as Antibiotics Stop Working
2 Biotech Buyout Candidates as Antibiotics Stop Working
24/7 Wall St
biotech
antibiotics
antibiotic resistance
Tetraphase Pharmaceuticals
Cempra
Flag link:
Pharma Stocks To Keep An Eye On: Pozen Inc. (POZN), Paratek Pharmaceuticals (PRTK), Oncothyreon Inc. (ONTY), Tetraphase Pharmaceuticals (TTPH)
Pharma Stocks To Keep An Eye On: Pozen Inc. (POZN), Paratek Pharmaceuticals (PRTK), Oncothyreon Inc. (ONTY), Tetraphase Pharmaceuticals (TTPH)
Bidness Etc.
Pozen
Tetraphase Pharmaceuticals
Paratek
Oncothyreon
Flag link:
Tetraphase spikes on a Phase III success for lead antibiotic
Tetraphase spikes on a Phase III success for lead antibiotic
Fierce Biotech
antibiotics
Tetraphase Pharmaceuticals
Eravacycline
Flag link:
Will Tetraphase Pharmaceuticals Be The Next Antibiotic-Maker To Be Acquired After Cubist Pharmaceuticals
Will Tetraphase Pharmaceuticals Be The Next Antibiotic-Maker To Be Acquired After Cubist Pharmaceuticals
Bidness Etc.
Tetraphase Pharmaceuticals
Cubist Pharma
Merck
M&A
Flag link:
Tetraphase Said to Explore Sale After Takeover Interest
Tetraphase Said to Explore Sale After Takeover Interest
Bloomberg
Tetraphase Pharmaceuticals
Flag link:
Tetraphase Oral Antibiotic Data Look Good
Tetraphase Oral Antibiotic Data Look Good
TheStreet.com
antibiotics
Tetraphase Pharmaceuticals
Eravacycline
Flag link:
Previewing Tetraphase Oral Antibiotic Study Results
Previewing Tetraphase Oral Antibiotic Study Results
TheStreet.com
Tetraphase Pharmaceuticals
antibiotics
Eravacycline
urinary tract infection
Flag link:
As Antibiotics Stop Working, Five Biotechs Seek Cures
As Antibiotics Stop Working, Five Biotechs Seek Cures
24/7 Wall St
antibiotic resistance
antibiotics
Cubist Pharmaceuticals
Durata
Insmed
Medicines Company
Tetraphase Pharmaceuticals
Flag link:
Tetraphase Pharmaceuticals: A Small Cap With Big Potential
Tetraphase Pharmaceuticals: A Small Cap With Big Potential
Seeking Alpha
Tetraphase Pharmaceuticals
AstraZeneca
Cubist Pharmaceuticals
antiobiotics
Eravacycline
JNJ
Merck
Pfizer
Flag link:
How Cellceutix Acquired A Next Generation Antibiotic For Pennies On The Dollar
How Cellceutix Acquired A Next Generation Antibiotic For Pennies On The Dollar
Seeking Alpha
Cellceutix
antibiotics
Organovo
Cubist Pharmaceuticals
Celgene
Trius Therapeutics
Tetraphase Pharmaceuticals
Pfizer
MRSA
Optimer Pharmaceuticals
Dificid
Brilacidin
Flag link:
Trius Acquired Last Week, Tetraphase Could Be Next
Trius Acquired Last Week, Tetraphase Could Be Next
Seeking Alpha
Trius Therapeutics
M&A
Tetraphase Pharmaceuticals
Cubist Pharmaceuticals
Optimer Pharmaceuticals
Pfizer
Flag link:
FDA Grants QIDP Designation to Eravacycline, Tetraphase’s Lead Antibiotic Product Candidate
FDA Grants QIDP Designation to Eravacycline, Tetraphase’s Lead Antibiotic Product Candidate
Yahoo
Eravacycline
Tetraphase Pharmaceuticals
antiobiotics
QIDP
Flag link:
3 Biotechs With Recent Intensive Insider Buying
3 Biotechs With Recent Intensive Insider Buying
Seeking Alpha
Tetraphase Pharmaceuticals
Enanta
Inovio
Flag link:

Pages